Difference between revisions of "AstraZeneca"

From Powerbase
Jump to: navigation, search
m (→‎Affiliations: added SMC funding info for 2014-15.)
 
(22 intermediate revisions by 8 users not shown)
Line 1: Line 1:
−
[[Image:AstraZeneca.gif|thumb|right|300px|AstraZeneca's logo]]
+
{{Template:Pharma_Portal_badge}}
−
==Company Name:==
+
'''AstraZeneca Plc''' is a pharmaceutical and biotechnology giant.
−
 
 
−
 
−
'''AstraZeneca Plc'''[http://www.astrazeneca.com/] is a [[Pharmaceutical Industry]] giant.
 
  
 
Astra (UK-based) and Zeneca (Sweden-based) merged in 1998 in one of the largest European mergers ever.<ref>Source: BBC News. Business: The Company File Zeneca and Astra merge to form drug giant. Online at: http://news.bbc.co.uk/1/hi/business/the_company_file/231213.stm Accessed 13 April 2008.</ref> AstraZeneca is UK-based and is active in 100 countries, with 67,000 employees.  
 
Astra (UK-based) and Zeneca (Sweden-based) merged in 1998 in one of the largest European mergers ever.<ref>Source: BBC News. Business: The Company File Zeneca and Astra merge to form drug giant. Online at: http://news.bbc.co.uk/1/hi/business/the_company_file/231213.stm Accessed 13 April 2008.</ref> AstraZeneca is UK-based and is active in 100 countries, with 67,000 employees.  
Line 23: Line 20:
 
*[[Council of Chief Risk Officers]] (Conference Board) [http://www.conference-board.org/memberservices/councilsDetailUS.cfm?Council_ID=147]
 
*[[Council of Chief Risk Officers]] (Conference Board) [http://www.conference-board.org/memberservices/councilsDetailUS.cfm?Council_ID=147]
 
*[[European Round Table of Industrialists]] [http://www.ert.be/]  
 
*[[European Round Table of Industrialists]] [http://www.ert.be/]  
−
*[[Science Media Centre]]
+
*[[AstraZeneca]] was a donor to the [[Science Media Centre]] from 2002 to 2013 according to the SMC.<ref>Data from Internet Archive holdings of the Science Media Centre website, 2002-2013.
 +
*Sept 2002 http://web.archive.org/web/20021224034413/http://www.sciencemediacentre.org/aboutus/fundingsystem.html
 +
*Apr 2003 http://web.archive.org/web/20030625193943/http://www.sciencemediacentre.org/aboutus/fundingsystem.html
 +
*Nov 2003 http://web.archive.org/web/20040214043237/http://www.sciencemediacentre.org/funding.htm
 +
*Oct 2004 http://web.archive.org/web/20041205182639/http://www.sciencemediacentre.org/funding.htm ; and http://web.archive.org/web/20051029205959/http://www.sciencemediacentre.org/funding.htm
 +
*Nov 2005 http://web.archive.org/web/20051227000834/http://www.sciencemediacentre.org/funding.htm
 +
*Apr 2006 http://web.archive.org/web/20060910221525/http://www.sciencemediacentre.org/funding.htm
 +
*Feb 2007 http://web.archive.org/web/20070829210611/http://www.sciencemediacentre.org/funding.htm
 +
*Jul 2008 http://web.archive.org/web/20081202143334/http://www.sciencemediacentre.org/pages/about/funding.htm
 +
*May 2009 http://web.archive.org/web/20090830202526/http://www.sciencemediacentre.org/pages/about/funding.htm
 +
*May 2010 http://web.archive.org/web/20100822091312/http://www.sciencemediacentre.org/pages/about/funding.htm
 +
*Jun 2011 http://web.archive.org/web/20110807075127/http://www.sciencemediacentre.org/pages/about/funding.htm
 +
*Aug 2012 http://web.archive.org/web/20120922235445/http://www.sciencemediacentre.org/pages/about/funding.htm
 +
*Aug 2013 Science Media Centre, 'Funding' August 2013 screengrab of http://www.sciencemediacentre.org/about-us/funding/, taken 16 August 2013.</ref> For the year 2014-15 AstraZeneca was listed on the Science Media Centre website as being in the £10,000 – £19,999 current donor bracket. <ref>[http://www.sciencemediacentre.org/about-us/funding/ SMC Funding 2014-15], Science Media Centre website. Last accessed 5 July 2016.</ref>
 
*[[Royal Institute of International Affairs]]
 
*[[Royal Institute of International Affairs]]
 
*[[International Federation of Pharmaceutical Manufacturers and Associations]]
 
*[[International Federation of Pharmaceutical Manufacturers and Associations]]
Line 34: Line 44:
  
  
−
[http://www.astrazeneca.com/mainnav1/about/cr/s_projects/project_list/c_projects_list/project-uk-cal-00-8.asp&#39;AZ UK&#39;s CALM Programme - AstraZeneca UK&#39;s CALM Programme] is designed to promote well-being by helping employees achieve the right balance between work and leisure.  The Programme aims to help people recognise signs of stress, and to provide routes of confidential support.&#39;
+
[http://www.astrazeneca.com/mainnav1/about/cr/s_projects/project_list/c_projects_list/project-uk-cal-00-8.asp AZ UK&#39;s CALM Programme - AstraZeneca UK&#39;s CALM Programme] is designed to promote well-being by helping employees achieve the right balance between work and leisure.  The Programme aims to help people recognise signs of stress, and to provide routes of confidential support.&#39;
  
−
[http://www.astrazeneca.com/mainnav1/about/cr/s_projects/project_list/c_projects_list/project-uk-hea-01-1.asp&#39;The Balanced Living Charter] launched in 2001, developed in response to the leadership team&#39;s concern about stress-related illness and is used as a basis for action to improve the management of pressure.  Its creation was intended for AstraZeneca staff working at the UK R&D sites to obtain the appropriate balance between work and home life and is intended to be used as a basis for action to improve the management of stress.&#39;
+
[http://www.astrazeneca.com/mainnav1/about/cr/s_projects/project_list/c_projects_list/project-uk-hea-01-1.asp The Balanced Living Charter] launched in 2001, developed in response to the leadership team&#39;s concern about stress-related illness and is used as a basis for action to improve the management of pressure.  Its creation was intended for AstraZeneca staff working at the UK R&D sites to obtain the appropriate balance between work and home life and is intended to be used as a basis for action to improve the management of stress.&#39;
  
−
[http://www.astrazeneca.com/mainnav1/about/cr/s_projects/project_list/c_projects_list/project-gl-ani-00-1.asp&#39;Reaching Out: AstraZeneca Anniversary] - to mark their first anniversary in June 2000, AstraZeneca reached out into their local communities around the world.  Examples include:  
+
[http://www.astrazeneca.com/mainnav1/about/cr/s_projects/project_list/c_projects_list/project-gl-ani-00-1.asp Reaching Out: AstraZeneca Anniversary] - to mark their first anniversary in June 2000, AstraZeneca reached out into their local communities around the world.  Examples include:  
 
1)  A trip to London Eye, hosted by the employees from Corporate Office in London for local schoolchildren who might otherwise not had the opportunity.
 
1)  A trip to London Eye, hosted by the employees from Corporate Office in London for local schoolchildren who might otherwise not had the opportunity.
 
2)  New science and maths books were donated to two local high schools for 1st year pupils by AstraZeneca R&D in Sodertajle, Sweden.
 
2)  New science and maths books were donated to two local high schools for 1st year pupils by AstraZeneca R&D in Sodertajle, Sweden.
Line 45: Line 55:
 
5)  In Thailand the company made a special donation of 100,000 Baht to a scholarship fund for medical students at Mahidol University.&#39;
 
5)  In Thailand the company made a special donation of 100,000 Baht to a scholarship fund for medical students at Mahidol University.&#39;
  
−
[http://www.astrazeneca.com/mainnav1/about/cr/s_projects/project_list/c_projects_list/project-uk-isc-00-10.asp&#39;The AstraZeneca &#39;Inspiring Science&#39; Programme for Schools] is run in conjunction with the CREST Awards Scheme in the UK, comprises a programme of project work that is enjoyable, relevant to the secondary education curriculum (ages 11-18) and designed to encourage young people&#39;s interest in science.  There is a competitive element to the programme, with regional competitions and a national final.  Cash prizes are offered to the schools of the students who deliver the best projects.&#39;
+
[http://www.astrazeneca.com/mainnav1/about/cr/s_projects/project_list/c_projects_list/project-uk-isc-00-10.asp The AstraZeneca &#39;Inspiring Science&#39; Programme for Schools] is run in conjunction with the CREST Awards Scheme in the UK, comprises a programme of project work that is enjoyable, relevant to the secondary education curriculum (ages 11-18) and designed to encourage young people&#39;s interest in science.  There is a competitive element to the programme, with regional competitions and a national final.  Cash prizes are offered to the schools of the students who deliver the best projects.&#39;
  
−
[http://www.astrazeneca.com/mainnav1/about/cr/s_projects/project_list/c_projects_list/project-uk-tra-00-4.asp &#39;Drivers for Change&#39;] is the name for Alderley Park site&#39;s Green Commuting project which has been operating since 1997 and is aimed at reducing &#39;single occupancy vehicles&#39; for staff travelling to work.  Car sharing, improved private and public bus services and the provision of cyclist and jogger changing facilities have meant an 8% reduction in car use on site.  This and a number of other projects associated with car travel by staff has won the Chief Executive&#39;s Award 2000 for Travel Safety.&#39;
+
[http://www.astrazeneca.com/mainnav1/about/cr/s_projects/project_list/c_projects_list/project-uk-tra-00-4.asp Drivers for Change] is the name for Alderley Park site&#39;s Green Commuting project which has been operating since 1997 and is aimed at reducing &#39;single occupancy vehicles&#39; for staff travelling to work.  Car sharing, improved private and public bus services and the provision of cyclist and jogger changing facilities have meant an 8% reduction in car use on site.  This and a number of other projects associated with car travel by staff has won the Chief Executive&#39;s Award 2000 for Travel Safety.&#39;
  
 
&#39;During 2001, AstraZeneca was included in the FTSE4Good Index and the Dow Jones Sustainability Index following independent assessment of their approach to CSR.&#39;<ref>Source: AstraZeneca Annual Review 2001, p 23.</ref>
 
&#39;During 2001, AstraZeneca was included in the FTSE4Good Index and the Dow Jones Sustainability Index following independent assessment of their approach to CSR.&#39;<ref>Source: AstraZeneca Annual Review 2001, p 23.</ref>
  
 
==PR, Lobbying and Business Intelligence agencies==
 
==PR, Lobbying and Business Intelligence agencies==
 +
*[[Finsbury]]<ref> [http://www.prca.org.uk/assets/files/Consultancy%20Register%20Sept-Nov%202014%20pdf(1).pdf Agency Register September to November 2014] ''PRCA'', accessed 29 January 2015 </ref>
 +
*[[Blue Rubicon]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=Open%20Road/Blue%20Rubicon Register 1st September 2014 - 30th November 2014] ''APPC'', accessed 28 January 2015 </ref>
 +
*[[Edelman]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=Edelman Register 1st September 2014 - 30th November 2014] ''APPC'', accessed 29 January 2015 </ref>
  
−
*[[Edelman]]
+
===Former===
−
AstraZeneca is listed as a client for [[Business Insights]]<ref> Business Insights [http://globalbusinessinsights.com/content/rbhc0019m.pdf Patient Power: The shift towards more informed, more powerful consumers of drugs] Accessed 5th February 2008</ref> and German PR company [[FischerAppelt Kommunikation]]<ref> FischerAppelt Kommunikation [http://translate.google.com/translate?hl=en&sl=de&u=http://www.fischerappelt.de/&sa=X&oi=translate&resnum=1&ct=result&prev=/search%3Fq%3DfischerAppelt%2BKommunikation%26hl%3Den%26client%3Dfirefox-a%26channel%3Ds%26rls%3Dorg.mozilla:en-GB:official%26hs%3Dgve%26sa%3DG Current & former clients] Accessed 14th February 2008</ref>
+
AstraZeneca was listed as a client for [[Business Insights]]<ref> Business Insights [http://globalbusinessinsights.com/content/rbhc0019m.pdf Patient Power: The shift towards more informed, more powerful consumers of drugs] Accessed 5th February 2008</ref> and German PR company [[FischerAppelt Kommunikation]]<ref> FischerAppelt Kommunikation [http://translate.google.com/translate?hl=en&sl=de&u=http://www.fischerappelt.de/&sa=X&oi=translate&resnum=1&ct=result&prev=/search%3Fq%3DfischerAppelt%2BKommunikation%26hl%3Den%26client%3Dfirefox-a%26channel%3Ds%26rls%3Dorg.mozilla:en-GB:official%26hs%3Dgve%26sa%3DG Current & former clients] Accessed 14th February 2008</ref>
  
−
In 2008, AstraZeneca is listed as a client for [[Innovex]]<ref> Innovex [http://www.innovexcareers.com/content_static/c_ourcustomers.asp?session_id={212F403D-EE9F-433B-A03A-E66AB35FB45E} Our Customers] Accessed 12th February 2008</ref> they are also listed as a member of the [[American Benefits Council]]<ref>American Benefits Council [http://www.americanbenefitscouncil.org/about/memberlist.cfm Memberships] Accessed 26th February 2008</ref>
+
In 2008, AstraZeneca was listed as a client for [[Innovex]]<ref> Innovex [http://www.innovexcareers.com/content_static/c_ourcustomers.asp?session_id={212F403D-EE9F-433B-A03A-E66AB35FB45E} Our Customers] Accessed 12th February 2008</ref> they are also listed as a member of the [[American Benefits Council]]<ref>American Benefits Council [http://www.americanbenefitscouncil.org/about/memberlist.cfm Memberships] Accessed 26th February 2008</ref>
 +
 
 +
==EU Lobbying==
 +
AstraZeneca have a lobbyist with a European Parliament pass, allowing the bearer virtually unlimited access to the Parliament's buildings.<ref> [http://lobbyfacts.eu/reports/staffing/companies?page=2 Companies declaring the most lobbyists] ''Lobby Facts'', 26 January 2015, accessed 3 February 2015 </ref>
  
 
==People==
 
==People==
−
*[[Tom McKiIIop]], former CEO
+
*[[Esra Erkal-Paler]], head of global media relations
 +
 
 +
===Former===
 +
*[[Tom McKiIIop]], CEO
  
 
==Patient Groups==
 
==Patient Groups==
Line 89: Line 108:
 
* [[MacMillan Cancer Support]]
 
* [[MacMillan Cancer Support]]
 
* [[UK Lung Cancer Coalition]]
 
* [[UK Lung Cancer Coalition]]
 +
 +
==Affiliations==
 +
*HM Treasury's Liaison Committee Review of Controlled Foreign Companies (CFC) Rules - company representative is [[Ian Brimicombe]] <ref> HM Treasury, CFC Review: List of Liaison Committee Members, acc 5 October 2011 </ref>
 +
 +
==Contact==
 +
Website http://www.astrazeneca.com/
  
 
==References==
 
==References==
Line 95: Line 120:
 
[[Category:Pharmaceutical Industry]]
 
[[Category:Pharmaceutical Industry]]
 
[[Category:Transnational Corporations]]
 
[[Category:Transnational Corporations]]
 +
[[Category:Big Pharma]][[Category:GM]][[Category:Human Genetics]]
 +
[[Category:Science Media Centre]]
 +
[[Category:EU Lobbying]]

Latest revision as of 11:44, 5 July 2016

Pharma badge.jpg This article is part of the Pharma_Portal project of Spinwatch.

AstraZeneca Plc is a pharmaceutical and biotechnology giant.

Astra (UK-based) and Zeneca (Sweden-based) merged in 1998 in one of the largest European mergers ever.[1] AstraZeneca is UK-based and is active in 100 countries, with 67,000 employees.

The company has six main therapy interest areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory & inflammation. AstraZeneca’s products include Seroquel (schizophrenia and bipolar disease).

  • Market Capital £m: 2000: 2001: 56,334.9 FT UK 500 (2001)
  • Turnover £m: 2001: 12,325.0 FT UK 500 (2001)

Affiliations

CSR (Corporate Social Responsibility) Ventures

'AstraZeneca Science Teaching Trust which in 2001 sponsored the 'Little Book of Experiments' which was distributed to UK primary schools as part of the National year of Science. programme.

In 2001, AstraZeneca's overall community spend totalled $19 million.' (Source: AstraZeneca Annual Review 2001, page 23)


AZ UK's CALM Programme - AstraZeneca UK's CALM Programme is designed to promote well-being by helping employees achieve the right balance between work and leisure. The Programme aims to help people recognise signs of stress, and to provide routes of confidential support.'

The Balanced Living Charter launched in 2001, developed in response to the leadership team's concern about stress-related illness and is used as a basis for action to improve the management of pressure. Its creation was intended for AstraZeneca staff working at the UK R&D sites to obtain the appropriate balance between work and home life and is intended to be used as a basis for action to improve the management of stress.'

Reaching Out: AstraZeneca Anniversary - to mark their first anniversary in June 2000, AstraZeneca reached out into their local communities around the world. Examples include: 1) A trip to London Eye, hosted by the employees from Corporate Office in London for local schoolchildren who might otherwise not had the opportunity. 2) New science and maths books were donated to two local high schools for 1st year pupils by AstraZeneca R&D in Sodertajle, Sweden. 3) Over 200 employees in Portugal donated their tickets to David Copperfield's Magic Show to underprivileged children in their community, 40 children with cancer and other illnesses and 50 people with learning difficulties. 4) In Argentina a taskforce was set up to co-ordinate a Respiratory Health Conference where patients, doctors and nurses from a local hospital were informed about asthma, its symptoms, causes and treatments. 5) In Thailand the company made a special donation of 100,000 Baht to a scholarship fund for medical students at Mahidol University.'

The AstraZeneca 'Inspiring Science' Programme for Schools is run in conjunction with the CREST Awards Scheme in the UK, comprises a programme of project work that is enjoyable, relevant to the secondary education curriculum (ages 11-18) and designed to encourage young people's interest in science. There is a competitive element to the programme, with regional competitions and a national final. Cash prizes are offered to the schools of the students who deliver the best projects.'

Drivers for Change is the name for Alderley Park site's Green Commuting project which has been operating since 1997 and is aimed at reducing 'single occupancy vehicles' for staff travelling to work. Car sharing, improved private and public bus services and the provision of cyclist and jogger changing facilities have meant an 8% reduction in car use on site. This and a number of other projects associated with car travel by staff has won the Chief Executive's Award 2000 for Travel Safety.'

'During 2001, AstraZeneca was included in the FTSE4Good Index and the Dow Jones Sustainability Index following independent assessment of their approach to CSR.'[4]

PR, Lobbying and Business Intelligence agencies

Former

AstraZeneca was listed as a client for Business Insights[8] and German PR company FischerAppelt Kommunikation[9]

In 2008, AstraZeneca was listed as a client for Innovex[10] they are also listed as a member of the American Benefits Council[11]

EU Lobbying

AstraZeneca have a lobbyist with a European Parliament pass, allowing the bearer virtually unlimited access to the Parliament's buildings.[12]

People

Former

Patient Groups

Agreements held between AstraZeneca and Patient Groups in 2007 for the UK[13]

Affiliations

  • HM Treasury's Liaison Committee Review of Controlled Foreign Companies (CFC) Rules - company representative is Ian Brimicombe [14]

Contact

Website http://www.astrazeneca.com/

References

  1. ↑ Source: BBC News. Business: The Company File Zeneca and Astra merge to form drug giant. Online at: http://news.bbc.co.uk/1/hi/business/the_company_file/231213.stm Accessed 13 April 2008.
  2. ↑ Data from Internet Archive holdings of the Science Media Centre website, 2002-2013.
  3. ↑ SMC Funding 2014-15, Science Media Centre website. Last accessed 5 July 2016.
  4. ↑ Source: AstraZeneca Annual Review 2001, p 23.
  5. ↑ Agency Register September to November 2014 PRCA, accessed 29 January 2015
  6. ↑ Register 1st September 2014 - 30th November 2014 APPC, accessed 28 January 2015
  7. ↑ Register 1st September 2014 - 30th November 2014 APPC, accessed 29 January 2015
  8. ↑ Business Insights Patient Power: The shift towards more informed, more powerful consumers of drugs Accessed 5th February 2008
  9. ↑ FischerAppelt Kommunikation Current & former clients Accessed 14th February 2008
  10. ↑ Innovex Our Customers Accessed 12th February 2008
  11. ↑ American Benefits Council Memberships Accessed 26th February 2008
  12. ↑ Companies declaring the most lobbyists Lobby Facts, 26 January 2015, accessed 3 February 2015
  13. ↑ AstraZeneca UKPatient Group Support Accessed 6th December 2007
  14. ↑ HM Treasury, CFC Review: List of Liaison Committee Members, acc 5 October 2011
Retrieved from "https://powerbase.info/index.php?title=AstraZeneca&oldid=237029"